Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease (Q71043285)
Jump to navigation
Jump to search
scientific article published on 01 January 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease |
scientific article published on 01 January 1996 |
Statements
Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease (English)
Zoldan J
Friedberg G